JENNIFER FORSTALL: Open Payments
NPI 1144993437 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,811 in 98 payments from 12 companies in 2025. Trend: 2023 $896 · 2024 $1,474 · 2025 $4,811
Food & beverage: $2,567Travel & lodging: $1,605Honoraria: $640
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 19 | $2,734 |
| Gilead Sciences, Inc. | 34 | $901 |
| Madrigal Pharmaceuticals | 21 | $386 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $311 |
| Janssen Scientific Affairs, LLC | 1 | $139 |
| Intercept Pharmaceuticals, Inc. | 5 | $78 |
| ABBVIE INC. | 1 | $77 |
| Veloxis Pharmaceuticals, Inc. | 3 | $70 |
| Novo Nordisk Inc | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
Products named: IQIRVO, REZDIFFRA, XIFAXAN, OCALIVA, LINZESS, ENVARSUS, Wegovy, LIVTENCITY.
Industry payments across LA — which companies pay providers there.
